GlaxoSmithKline

GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment

Promising COVID-19 antibody therapy significantly reduces risk of hospitalization, death

GSK and Sanofi shares fall as the pharma giants delay COVID-19 vaccine until late 2021

U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine

Sanofi and GlaxoSmithKline are teaming up to develop a coronavirus vaccine